The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia

Journal of Vascular Surgery

Volumn 50, Issue 4, 2009, Pages 806-812

  Söderström, Maria ^a   Vikatmaa, Pirkka ^a   Lepäntalo, Mauri ^a   Aho, Pekka Sakari ^a   Kolho, Elina ^a   Ikonen, Tuija ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BYPASS SURGERY; CONTROLLED STUDY; FEMALE; GRAFT PATENCY; GRAFT SURVIVAL; HUMAN; LEG ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOPLASTY; ANTI-BACTERIAL AGENTS; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; CRITICAL ILLNESS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LEG; LIMB SALVAGE; MALE; MIDDLE AGED; PROBABILITY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS;

EID: 70349311270     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.05.063     Document Type: Article

References (17)

1. Aloush V., Navon-Venezia S., Seigman-Igra Y., Cabili S., and Carmeli Y. Multi-drug resistant Pseudomonas aeruginosa; risk factors and clinical impact. Antimicrob Agents Chemother 50 (2006) 43-48
2. Agodi A., Barchitta M., Cipreso R., Giaquinta L., Romeo M., and Denaro C. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med 33 (2007) 1155-1161
3. Hocquet D., Berthelot P., Roussel-Delvallez M., Favre R., Jeannot K., Bajolet O., et al. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 10 (2007) 3531-3536
4. Hancock R. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 27 suppl 1 (1998) S93-S99
5. Lyytikäinen O., Golovanova V., Kolho E., Ruutu P., Sivonen A., Tiittanen L., et al. Outbreak caused by Tobramycin-resistant Pseudomonas auruginosa in a Bone Marrow Transplantation Unit. Scand J Infect Dis 33 (2001) 445-449
6. Cao B., Wang H., Sun H., Zhu Y., and Chen M. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect 57 (2004) 112-118
7. Zavascki A., Barth A., Gonçalves A., Moro A., Fernandes J., Martins A., et al. The influence of metallo-ß-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 58 (2006) 387-392
8. Gasink L., Fishman N., Weiner M., Nachamkin I., Bilker W., and Lautenbach E. Fluoroquinolone-resistant Pseudomonas aeruginosa assessment of risk factors and clinical impact. Am J Med 119 (2006) 526e19-25
9. Bandyk D.F. vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg 21 (2008) 119-123
10. Fontaine R., Klm M., and Kieny R. Die chirurgische Behandlungen der peripheren Durchblutungsstörungen. Helv Chir Acta 36 (1955) 499-533
11. Giske C., Monnet D., Cars O., and Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52 (2008) 813-820
12. Ortega B., Groeneveld J., and Schultsz C. Endemic multi-drug resistant Pseudomonas aeruginosa in critically ill patients. Infect Control Hosp Epidemiol 25 (2004) 825-831
13. Kang C., Kim S., Park W., Lee K., Kim H., Kim E., et al. Risk factors for antimikrobial resistance and influence of resistance on mortality in patients with bloodstream infections caused by Pseudomonas aeruginosa. Microb Drug Resist 11 (2005) 68-74
14. Sawyer R., and Pruett T. Wound infections. Surg Clin North Am 74 (1994) 519-536
15. Kent K., Bartek S., Kuntz K., Anninos E., and Skillman J. Prospective study of wound complications in continuous infrainguinal incisions after lower limb arterial reconstructions: Incidence, risk factors and cost. Surgery 119 (1996) 378-383
16. Richet H., Chidiac C., Prat A., Pol A., David M., Maccario M., et al. Analysis of risk factors for surgical wound infections following vascular surgery. Am J Med 91 (1991) 170-172S
17. Bandyk D., and Back M. Infection in prosthetic vascular grafts. In: Rutherford (Ed). Vascular surgery (2005), Elsevier Saunders, Philadelphia 875